Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?16.80

?16.80

 
WKN: A2AQDJ / Symbol: PAVM / Name: PAVmed / Stock / Healthcare Equipment & Supplies / Micro Cap /
Latest predictions
€14.60
10.12.25
-
buy
11.10.25
-
buy
€17.06
06.10.25
-
buy
€16.60
06.06.25
-
buy
€16.99
21.04.25
-
buy
Your prediction

PAVmed Inc Stock

Our community is currently high on PAVmed Inc with 5 Buy predictions and 0 Sell predictions.
Based on the current price of 0.2 € the target price of 16 € shows a potential of 7820.79% for PAVmed Inc which would more than double the current price.
For the coming years our community has positive and negative things to say abot the PAVmed Inc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Expected dividend yield" there were negative voices in the community.

Pros and Cons of PAVmed Inc in the next few years

Pros
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) -
Target price 14.596
Change
Ends at 10.12.26

PAVmed (NASDAQ:PAVM) had its price target lowered by analysts at Ascendiant Capital Markets from $20.00 to $17.00. They now have a "buy" rating on the stock.
Ratings data for PAVM provided by MarketBeat
Show more

PAVmed (NASDAQ:PAVM) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ratings data for PAVM provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 17.060
Change
Ends at 06.10.26

PAVmed (NASDAQ:PAVM) had its price target raised by analysts at Ascendiant Capital Markets from $19.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for PAVM provided by MarketBeat
Show more

News

PAVmed Revenue Jumps 513% in Q2
PAVmed Revenue Jumps 513% in Q2

PAVmed (NASDAQ:PAVM), a medical technology innovator focused on minimally invasive diagnostics and digital health devices, published its earnings results on August 14, 2025. The headline news was a